Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 36,800
-850 (-2.26%)
Last updated: Feb 26, 2026, 10:34 AM KST
Ildong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 27,923 | -4,576 | -78,928 | -141,585 | -99,705 | -13,019 |
Depreciation & Amortization | 24,023 | 25,935 | 28,319 | 29,545 | 29,311 | 27,663 |
Loss (Gain) From Sale of Assets | 6,124 | 4,908 | -1,133 | 282.22 | 101.53 | -2,029 |
Asset Writedown & Restructuring Costs | 5,757 | 9,857 | 3,492 | 19,004 | 550.27 | 7,928 |
Loss (Gain) From Sale of Investments | -9,625 | -1,955 | -439.72 | -2,325 | 862.82 | 5,222 |
Loss (Gain) on Equity Investments | -147.76 | 273.49 | 0.36 | 0.54 | 1.67 | - |
Stock-Based Compensation | 292.96 | 129.79 | -5.73 | 18.09 | 16.55 | 30.92 |
Provision & Write-off of Bad Debts | 558.19 | 303.04 | -574.49 | -85.1 | -1,142 | -283.8 |
Other Operating Activities | -9,931 | 1,449 | 24,140 | 56,020 | 60,178 | 16,763 |
Change in Accounts Receivable | -1,838 | 3,634 | -2,089 | -1,407 | -1,857 | 13,386 |
Change in Inventory | -11,040 | -2,508 | 13,852 | -15,532 | 6,617 | -19,036 |
Change in Accounts Payable | -3,142 | -2,973 | 4,235 | 7,936 | 2,339 | -3,724 |
Change in Other Net Operating Assets | -8,023 | -6,185 | -27,484 | -5,412 | -8,639 | -13,535 |
Operating Cash Flow | 20,931 | 28,293 | -36,615 | -53,541 | -11,366 | 19,366 |
Operating Cash Flow Growth | -23.40% | - | - | - | - | -53.18% |
Capital Expenditures | -14,256 | -10,679 | -13,201 | -11,873 | -14,626 | -14,352 |
Sale of Property, Plant & Equipment | 29,237 | 29,336 | 307.01 | 67.5 | 38.14 | 60 |
Divestitures | 184.32 | 79.74 | - | - | 4,142 | - |
Sale (Purchase) of Intangibles | -3,490 | -1,150 | -1,968 | -6,401 | -4,876 | -2,572 |
Investment in Securities | -9,533 | 12,759 | -1,601 | -7,401 | -26,180 | -2,240 |
Other Investing Activities | -20,488 | -344.22 | 1,025 | -842.62 | 1,133 | 196.66 |
Investing Cash Flow | -15,610 | 18,458 | -20,360 | -26,435 | -43,368 | -18,403 |
Short-Term Debt Issued | - | 15,030 | 84,500 | 23,000 | 141,600 | 198,600 |
Long-Term Debt Issued | - | 50,000 | 29,250 | 17,000 | 99,400 | 42,000 |
Total Debt Issued | 24,323 | 65,030 | 113,750 | 40,000 | 241,000 | 240,600 |
Short-Term Debt Repaid | - | -87,519 | -48,700 | -20,000 | -133,600 | -207,600 |
Long-Term Debt Repaid | - | -3,573 | -4,850 | -23,118 | -10,723 | -37,532 |
Total Debt Repaid | -38,415 | -91,092 | -53,550 | -43,118 | -144,323 | -245,132 |
Net Debt Issued (Repaid) | -14,092 | -26,062 | 60,200 | -3,118 | 96,677 | -4,532 |
Issuance of Common Stock | - | - | 124.83 | - | 1,745 | - |
Repurchase of Common Stock | -0.69 | -0.17 | -1,942 | - | - | -43.34 |
Dividends Paid | -60.16 | -76.8 | -160 | -120 | - | - |
Other Financing Activities | 8,198 | -1,715 | -70.4 | -49.31 | -0 | - |
Financing Cash Flow | -4,590 | -27,854 | 58,152 | -3,287 | 104,316 | -4,576 |
Foreign Exchange Rate Adjustments | 32.52 | 112.18 | -64.19 | -177.2 | 440.44 | -782.09 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | 764.07 | 19,009 | 1,112 | -83,440 | 50,022 | -4,395 |
Free Cash Flow | 6,675 | 17,614 | -49,817 | -65,413 | -25,992 | 5,014 |
Free Cash Flow Growth | -61.56% | - | - | - | - | -82.89% |
Free Cash Flow Margin | 1.16% | 2.86% | -8.29% | -10.26% | -4.64% | 0.89% |
Free Cash Flow Per Share | 234.51 | 630.60 | -1843.01 | -2483.08 | -1092.76 | 210.79 |
Cash Interest Paid | 8,376 | 13,534 | 10,412 | 5,643 | 4,041 | 2,711 |
Cash Income Tax Paid | 2,040 | 560.83 | 724.88 | 2,524 | -290.57 | 2,439 |
Levered Free Cash Flow | -41,102 | -6,707 | 5,487 | -159,418 | 101,154 | -1,447 |
Unlevered Free Cash Flow | -32,362 | 3,254 | 14,690 | -153,300 | 107,752 | 1,471 |
Change in Working Capital | -24,042 | -8,032 | -11,485 | -14,416 | -1,540 | -22,910 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.